Search

everythinglearnresearchcommunity

for

Search:↓

Linoleic acid and magnesium are key in alopecia areata progression, and tofacitinib can help by affecting their pathway.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

AI improves biomaterial design by making it faster, cheaper, and more effective for personalized medicine.

AI improves vascular surgery by enhancing precision and safety, but doctors make final decisions.

New treatments and strategies are needed for Alopecia Areata, focusing on immune response and better trial designs.

JAK inhibitors like tofacitinib can effectively treat severe alopecia areata.

IL-1α levels are higher in alopecia areata patients, suggesting a role in the disease.

Baricitinib was effective in regrowing hair in patients with different levels of alopecia areata severity.

Alopecia areata severity is influenced by factors like long disease duration, relapses, treatment response, and mental health, leading to the creation of a new severity measurement tool.

Analog 23 is a promising compound for prostate cancer treatment.

The study was retracted.

IL-15 promotes hair growth and protects hair follicles.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

Melanogenesis-related proteins may trigger immune responses in alopecia areata patients.

AGD1's PH domain is essential for its role in root hair growth and polarity.

A rare form of alopecia causes hair thinning without bald spots and may be more common than thought, responding well to steroid treatment.

Urban air pollution worsens hair loss in alopecia areata by increasing immune response.

Mutations in the PADI3 gene may cause central centrifugal cicatricial alopecia in women of African ancestry.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

PAD3 plays a key role in hair and skin protein structure and may be linked to skin diseases.

Hair loss gene found on chromosome 3q26.

Different types of atopic dermatitis were linked to specific genetic and immune changes, suggesting that severe cases might need stronger immune-targeting treatments.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

Diffuse alopecia areata involves more inflammation and higher allergy-related antibodies than patchy types.

Alopecia areata may appear differently depending on the individual's type of hair loss and scalp condition.

The study developed a mouse model for Alopecia Areata that responds to treatment, useful for future research.

JAK inhibitors improve hair growth in alopecia areata, especially in patchy types.

ChatGPT 4.0 and Gemini 1.5 Flash are effective for educating patients about androgenetic alopecia, while Deepseek R1 is less reliable.